Immunoporosis: The hidden link between aging immune cells and bone fragility

Area of Science:

• Immunology
• Gerontology
• Bone Biology

Background:

• Osteoporosis (OP) is a major global health issue in the elderly.
• Immune system aging (immunosenescence) significantly contributes to OP development, termed 'immunoporosis'.
• Age-related immune cell changes disrupt bone metabolism, promoting bone loss.

Purpose of the Study:

• To review the relationship between immunosenescence and bone biology.
• To elucidate molecular and cellular mechanisms linking aging immunity to OP.
• To identify immunosenescence as a therapeutic target for skeletal health.

Main Methods:

• Literature review of current research on immunosenescence and bone.
• Analysis of molecular pathways, including SASP and inflammaging.
• Integration of preclinical and clinical data on immunosenescence markers and OP.

Main Results:

• Immunosenescence alters immune cells, promoting osteoclastogenesis and impairing osteogenesis.
• Senescence-associated secretory phenotype (SASP) factors contribute to bone loss.
• Clinical studies link immunosenescence markers (e.g., CD4+ CD28- T cells, TNF-α, IL-6) to low bone mineral density.

Conclusions:

• Immunosenescence is a key driver of osteoporosis in aging populations.
• Targeting senescent immune cells or their secretions offers potential therapeutic strategies.
• Immunosenescence markers can identify high-risk individuals for early intervention.